Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles

DM Griffith, H Li, MV Werrett, PC Andrews… - Chemical Society …, 2021 - pubs.rsc.org
Bismuth as a relatively non-toxic and inexpensive metal with exceptional properties has
numerous biomedical applications. Bismuth-based compounds are used extensively as …

Applications of radiocomplexes with thiosemicarbazones and bis (thiosemicarbazones) in diagnostic and therapeutic nuclear medicine

GL Parrilha, RG dos Santos, H Beraldo - Coordination Chemistry Reviews, 2022 - Elsevier
Metallic radionuclides possess a variety of half-lives, emission types, energies, and
branching ratios, making it possible to apply them as diagnostic and/or therapeutic agents …

Bismuth-213 for targeted radionuclide therapy: from atom to bedside

S Ahenkorah, I Cassells, CM Deroose, T Cardinaels… - Pharmaceutics, 2021 - mdpi.com
In contrast to external high energy photon or proton therapy, targeted radionuclide therapy
(TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and …

[HTML][HTML] Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review

H Siebinga, MDM Stokkel, ADR Huitema… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Physiologically based pharmacokinetic (PBPK) and population pharmacokinetic
(PK) modelling approaches are widely accepted in non-radiopharmaceutical drug …

Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation

S Dhoundiyal, S Srivastava, S Kumar, G Singh… - European Journal of …, 2024 - Springer
This review article explores the dynamic field of radiopharmaceuticals, where innovative
developments arise from combining radioisotopes and pharmaceuticals, opening up …

Automated GMP compliant production of [18F]AlF-NOTA-octreotide

T Tshibangu, C Cawthorne, K Serdons… - EJNMMI radiopharmacy …, 2020 - Springer
Background Gallium-68 labeled synthetic somatostatin analogs for PET/CT imaging are the
current gold standard for somatostatin receptor imaging in neuroendocrine tumor patients …

Production review of accelerator-based medical isotopes

Y Wang, D Chen, R dos Santos Augusto, J Liang, Z Qin… - Molecules, 2022 - mdpi.com
The production of reactor-based medical isotopes is fragile, which has meant supply
shortages from time to time. This paper reviews alternative production methods in the form of …

[HTML][HTML] 3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals

S Ahenkorah, E Murce, C Cawthorne, JP Ketchemen… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Radiolabeled somatostatin analogues (eg [68 Ga] Ga-DOTATATE and [177 Lu]
Lu-DOTATATE) have been used to diagnose, monitor, and treat neuroendocrine tumour …

Targeted Alpha Therapy: All We Need to Know about 225Ac's Physical Characteristics and Production as a Potential Theranostic Radionuclide

W Jalloul, V Ghizdovat, CR Stolniceanu, T Ionescu… - Pharmaceuticals, 2023 - mdpi.com
The high energy of α emitters, and the strong linear energy transfer that goes along with it,
lead to very efficient cell killing through DNA damage. Moreover, the degree of oxygenation …

Design, Synthesis, and Evaluation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein for Brain Imaging

Z Yu, Y Huang, H Chen, Z Jiang, C Li… - ACS Pharmacology & …, 2023 - ACS Publications
Fibroblast activation protein (FAP) is closely related to central nervous system diseases such
as stroke and brain tumors, but PET tracers that can be used for brain imaging have not …